Clene Inc

NASDAQ:CLNN

11.09

-0.76 (-6.41%)

Market Cap (Intraday)	36.04M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.08 Million
Adjusted EPS	-$0.16

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Clene Inc Stock, NASDAQ:CLNN

6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121

Virgin Islands, British

Phone: +1.801.676.9695

Number of Employees:

http://www.clene.com

Description

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.